Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psych Congress Network
“Evenamide has the potential to treat the symptoms of schizophrenia more broadly, addressing also those poorly managed by the currently available antipsychotics.” — Ravi Anand, MD, Therapeutic Advances in Psychopharmacology
Psychiatry February 18th 2026
Cleveland Clinic Journal of Medicine (CCJM)
Deprescribing benzodiazepines in patients on long-term stable treatment led to increased mortality along with increases in nonfatal overdoses, suicidal ideation, and emergency department visits.
Psychiatry January 21st 2026
MedCentral
“These drugs are not weight loss drugs. “These are not diabetes drugs. These are drugs that have multiple purposes, including obesity and diabetes, and possibly they might even help protect the brain.” – Roger McIntyre, MD
Endocrinology, Diabetes, Metabolism January 21st 2026
Pharmacy Learning Network
“Pharmacies exist to heal the sick, not to fuel addiction and line the pockets of drug traffickers.” – DEA Administrator Terrance Cole
Clinical Pharmacology December 11th 2025
Medical Xpress
As cannabis becomes more widely available and socially accepted and legalized in various jurisdictions, it is essential to understand its potential health risks and the need for health care professionals to routinely talk to patients about cannabis use.
Endocrinology, Diabetes, Metabolism September 15th 2025
Journal of the American Pharmacists Association (JAPhA)
“I feel very confident [having the pharmacist involved], and I can say I do trust my pharmacist to do it. And I feel like my pharmacist may be the one to actually get me to stop smoking.”
Clinical Pharmacology September 3rd 2025